Prestige Biologics Co Ltd (334970) Stock Price & News

334970:KOSDAQ

Prestige Biologics Co Ltd

₩1,179.00

+0.86%

(+10.00) 1D

Nov 4, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 334970...

Open

₩1,169

High

₩1,228

Low

₩1,099

Mkt. cap

91.67B

Avg. vol.

169.33K

Volume

609.29K

52-wk high

₩3,850

52-wk low

₩1,010

EPS

-₩659

Shares outstanding

77.75M

No. of employees

321

Open

₩1,169

High

₩1,228

Low

₩1,099

Mkt. cap

91.67B

Avg. vol.

169.33K

Volume

609.29K

52-wk high

₩3,850

52-wk low

₩1,010

EPS

-₩659

Shares outstanding

77.75M

No. of employees

321

Related stocks

003060

Aprogen Biologics Inc

Hanall Biopharma Co Ltd

₩37,150.00

0.00%

News stories

From web sources and news partners

FinancialContent

39 minutes ago

Allstate (NYSE:ALL) reports sales below analyst estimates in Q3 2026 earnings

WTTW News

56 minutes ago

Dow Has Best Post-Midterm Elections Day in 44 Years as Democrats Take Control of Congress

MarketWatch

40 minutes ago

This year’s worst-performing S&P 500 stock is finally seeing some major relief

PBS

2 hours ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About Prestige Biologics Co Ltd

CEOJae-young Yang

Employees321

Founded2015

Headquarters-

SectorBiotechnology

Industry-

Websiteprestigebiologics.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.17B	8.90B	2.27B	14.32B
Cost of goods sold	2.53B	13.39B	11.62B	18.54B
Cost of revenue	2.53B	13.39B	11.62B	18.54B
Research and development expenses	9.24B	3.33B	5.17B	2.48B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.71B	1.02B	912.15M	2.01B
Operating expense	12.23B	5.26B	6.98B	5.42B
Total operating expenses	14.76B	18.65B	18.60B	23.96B
Operating income	-13.59B	-9.74B	-16.33B	-9.64B
Other non operating income	2.47B	3.51B	3.00B	1.48B
EBT including unusual items	-12.93B	-8.28B	-14.65B	-15.36B
EBT excluding unusual items	-12.93B	-8.28B	-14.65B	-10.12B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	98.70M	54.71M	35.38M	78.37M
Net income	-12.93B	-8.28B	-14.65B	-15.36B
Net profit margin	-1,106.66%	-93.03%	-645.47%	-107.22%
Earnings per share	-	-	-	-
Interest and investment income	3.37M	6.13M	6.04M	31.95M
Interest expense	-1.79B	-1.84B	-1.28B	-2.01B
Net interest expenses	-1.79B	-1.83B	-1.27B	-1.98B
Depreciation and amortization charges	1.17B	847.38M	841.85M	836.25M
EBITDA	-9.71B	-5.74B	-12.25B	-4.73B
Gain or loss from assets sale	1.74M	-	-	-

Finance

Ask anything